title: [Melanoma during pregnancy].
authors.affiliation: Service de dermatologie, hôpital Saint-Louis, AP-HP, 1 avenue Claude-Vellefaux, Paris cedex 10, France.
authors.forename: C
authors.initials: C
authors.lastname: Pagès
authors.forename: J-L
authors.initials: JL
authors.lastname: Misset
authors.forename: E
authors.initials: E
authors.lastname: de Kerviler
authors.forename: F
authors.initials: F
authors.lastname: Bavoux
authors.forename: H
authors.initials: H
authors.lastname: Fernandez
authors.forename: M
authors.initials: M
authors.lastname: Viguier
mesh_terms: D000014:Abnormalities, Drug-Induced; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003952:Diagnostic Imaging; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D008431:Maternal-Fetal Exchange; D008545:Melanoma / Q000175:diagnosis / Q000453:epidemiology / Q000556:secondary / Q000628:therapy*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D011379:Prognosis; D021701:Sentinel Lymph Node Biopsy; D012878:Skin Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000556:secondary / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D007155:Immunologic Factors; D016898:Interferon-alpha